volume 15 issue 12 pages 740-755

Targeting microbial biofilms: current and prospective therapeutic strategies

HYUN KOO 1
Raymond N Allan 2, 3
Robert P. Howlin 4, 5
Paul Stoodley 6, 7, 8
Luanne Hall-Stoodley 5, 6
Publication typeJournal Article
Publication date2017-09-25
scimago Q1
wos Q1
SJR13.861
CiteScore106.4
Impact factor103.3
ISSN17401526, 17401534
Microbiology
Infectious Diseases
General Immunology and Microbiology
Abstract
Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections. The multifactorial nature of biofilm development and drug tolerance imposes great challenges for the use of conventional antimicrobials and indicates the need for multi-targeted or combinatorial therapies. In this Review, we focus on current therapeutic strategies and those under development that target vital structural and functional traits of microbial biofilms and drug tolerance mechanisms, including the extracellular matrix and dormant cells. We emphasize strategies that are supported by in vivo or ex vivo studies, highlight emerging biofilm-targeting technologies and provide a rationale for multi-targeted therapies aimed at disrupting the complex biofilm microenvironment.
Found 
Found 

Top-30

Journals

5
10
15
20
25
30
35
40
45
Frontiers in Microbiology
44 publications, 2.97%
Antibiotics
27 publications, 1.82%
International Journal of Molecular Sciences
26 publications, 1.75%
ACS applied materials & interfaces
25 publications, 1.69%
Chemical Engineering Journal
23 publications, 1.55%
ACS Nano
20 publications, 1.35%
Scientific Reports
19 publications, 1.28%
Advanced Functional Materials
19 publications, 1.28%
Journal of Materials Chemistry B
18 publications, 1.21%
Advanced healthcare materials
17 publications, 1.15%
Microorganisms
15 publications, 1.01%
ACS Infectious Diseases
15 publications, 1.01%
Pharmaceutics
15 publications, 1.01%
Nature Communications
15 publications, 1.01%
Molecules
14 publications, 0.94%
Advanced Materials
14 publications, 0.94%
Small
13 publications, 0.88%
Frontiers in Cellular and Infection Microbiology
13 publications, 0.88%
Colloids and Surfaces B: Biointerfaces
12 publications, 0.81%
Biomaterials Science
12 publications, 0.81%
Biofouling
12 publications, 0.81%
ACS Applied Bio Materials
11 publications, 0.74%
Journal of Controlled Release
11 publications, 0.74%
Advanced Science
11 publications, 0.74%
Frontiers in Bioengineering and Biotechnology
10 publications, 0.67%
International Journal of Biological Macromolecules
10 publications, 0.67%
npj Biofilms and Microbiomes
9 publications, 0.61%
Biofilm
9 publications, 0.61%
BMC Microbiology
8 publications, 0.54%
5
10
15
20
25
30
35
40
45

Publishers

50
100
150
200
250
300
350
400
Elsevier
387 publications, 26.1%
Springer Nature
197 publications, 13.28%
MDPI
176 publications, 11.87%
Wiley
163 publications, 10.99%
American Chemical Society (ACS)
122 publications, 8.23%
Frontiers Media S.A.
94 publications, 6.34%
Royal Society of Chemistry (RSC)
77 publications, 5.19%
Taylor & Francis
55 publications, 3.71%
American Society for Microbiology
31 publications, 2.09%
Cold Spring Harbor Laboratory
25 publications, 1.69%
American Association for the Advancement of Science (AAAS)
11 publications, 0.74%
Oxford University Press
10 publications, 0.67%
Bentham Science Publishers Ltd.
9 publications, 0.61%
SAGE
9 publications, 0.61%
Hindawi Limited
9 publications, 0.61%
Public Library of Science (PLoS)
8 publications, 0.54%
Ovid Technologies (Wolters Kluwer Health)
7 publications, 0.47%
IOP Publishing
4 publications, 0.27%
American Society for Clinical Investigation
3 publications, 0.2%
Microbiology Society
3 publications, 0.2%
Research Square Platform LLC
3 publications, 0.2%
American Scientific Publishers
2 publications, 0.13%
Institution of Engineering and Technology (IET)
2 publications, 0.13%
Mary Ann Liebert
2 publications, 0.13%
Japan Institute of Metals
2 publications, 0.13%
Cambridge University Press
2 publications, 0.13%
Pleiades Publishing
2 publications, 0.13%
Veterinary World
2 publications, 0.13%
F1000 Research
2 publications, 0.13%
50
100
150
200
250
300
350
400
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
1.5k
Share
Cite this
GOST |
Cite this
GOST Copy
KOO H. et al. Targeting microbial biofilms: current and prospective therapeutic strategies // Nature Reviews Microbiology. 2017. Vol. 15. No. 12. pp. 740-755.
GOST all authors (up to 50) Copy
KOO H., Allan R. N., Howlin R. P., Stoodley P., Hall-Stoodley L. Targeting microbial biofilms: current and prospective therapeutic strategies // Nature Reviews Microbiology. 2017. Vol. 15. No. 12. pp. 740-755.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1038/nrmicro.2017.99
UR - https://doi.org/10.1038/nrmicro.2017.99
TI - Targeting microbial biofilms: current and prospective therapeutic strategies
T2 - Nature Reviews Microbiology
AU - KOO, HYUN
AU - Allan, Raymond N
AU - Howlin, Robert P.
AU - Stoodley, Paul
AU - Hall-Stoodley, Luanne
PY - 2017
DA - 2017/09/25
PB - Springer Nature
SP - 740-755
IS - 12
VL - 15
PMID - 28944770
SN - 1740-1526
SN - 1740-1534
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2017_KOO,
author = {HYUN KOO and Raymond N Allan and Robert P. Howlin and Paul Stoodley and Luanne Hall-Stoodley},
title = {Targeting microbial biofilms: current and prospective therapeutic strategies},
journal = {Nature Reviews Microbiology},
year = {2017},
volume = {15},
publisher = {Springer Nature},
month = {sep},
url = {https://doi.org/10.1038/nrmicro.2017.99},
number = {12},
pages = {740--755},
doi = {10.1038/nrmicro.2017.99}
}
MLA
Cite this
MLA Copy
KOO, HYUN, et al. “Targeting microbial biofilms: current and prospective therapeutic strategies.” Nature Reviews Microbiology, vol. 15, no. 12, Sep. 2017, pp. 740-755. https://doi.org/10.1038/nrmicro.2017.99.